Literature DB >> 13606330

Observations on the antituberculous effectiveness of alpha-ethyl-thioisonicotinamide in tuberculosis in humans.

G BROUET, J MARCHE, N RIST, J CHEVALLIER, G LEMEUR.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS, PULMONARY/therapy

Mesh：

Year:  1959        PMID： 13606330     DOI： 10.1164/artpd.1959.79.1.6

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  5 in total

1.  [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].

Authors:  M LEHIR; J CHICOU; G HETRICK; A MERCIER; R NEEL; N RIST
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  Chronic pulmonary tuberculosis treatment with ethionamide combined with cycloserine or oxytetracycline.

Authors:  G B CLARKE; A J O'HEA
Journal:  Br Med J       Date:  1961-03-04

3.  Deterioration of cycloserine in the tropics.

Authors:  K V Rao; L Eidus; C Evans; S Kailasam; S Radhakrishna; P R Somasundaram; H Stott; S Subbammal; S P Tripathy
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  Antimicrobial therapy of pulmonary tuberculosis.

Authors:  W McDermott
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

Review 5.  MDR Tuberculosis Treatment.

Authors:  Juan Espinosa-Pereiro; Adrian Sánchez-Montalvá; Maria Luisa Aznar; Maria Espiau
Journal:  Medicina (Kaunas)       Date:  2022-01-26       Impact factor: 2.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.